Qingsong Health Shares Surge Over 20% in Afternoon Trading Following Strategic Partnership Announcement for Southeast Asia Expansion

Stock News06-22

Qingsong Health (HKEX: 02661) shares experienced a significant surge of over 20% in afternoon trading. At the time of writing, the stock was up 14.21% to HK$15.81, with a trading volume of HK$211 million.

Catalyst for the Move

The recent price movement follows the company's announcement that it has entered into a three-year strategic cooperation memorandum with Basel Medical Group Limited (Basel Medical, NASDAQ: BMGL).

The collaboration is centered around leveraging Qingsong Health's proprietary MedClaw healthcare AI collaboration system and AIcare technology stack, along with its extensive experience in implementing AI within the health sector. The primary goal is to foster mutual development through both technology export and iterative technological advancements.

Both parties believe that integrating the company's proven health AI infrastructure with Basel Medical's established clinical presence and market access in Southeast Asia will accelerate the region's transition towards intelligent healthcare services. This partnership is expected to unlock new market opportunities for both entities.

Furthermore, the companies plan to utilize the Qingsong Health AIcare technology stack as a foundation. This will support Basel Medical in upgrading its medical services with AI-native solutions across Southeast Asia and jointly expanding their regional market footprint, aiming to establish a durable and stable strategic partnership.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1198594758?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-22 14:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198594758","market":"sg","top_or_hot":-1,"title":"Qingsong Health Shares Surge Over 20% in Afternoon Trading Following Strategic Partnership Announcement for Southeast Asia Expansion","media":"Stock News","content":"<p><b>Qingsong Health</b> (<b>HKEX: 02661</b>) shares experienced a significant surge of over 20% in afternoon trading. At the time of writing, the stock was up 14.21% to HK$15.81, with a trading volume of HK$211 million.<br><br>\n<b>Catalyst for the Move</b><br><br>The recent price movement follows the company's announcement that it has entered into a three-year strategic cooperation memorandum with Basel Medical Group Limited (<b>Basel Medical</b>, <b>NASDAQ: BMGL</b>).<br><br>\nThe collaboration is centered around leveraging <b>Qingsong Health</b>'s proprietary MedClaw healthcare AI collaboration system and AIcare technology stack, along with its extensive experience in implementing AI within the health sector. The primary goal is to foster mutual development through both technology export and iterative technological advancements.<br><br>\nBoth parties believe that integrating the company's proven health AI infrastructure with <b>Basel Medical</b>'s established clinical presence and market access in Southeast Asia will accelerate the region's transition towards intelligent healthcare services. This partnership is expected to unlock new market opportunities for both entities.<br><br>\nFurthermore, the companies plan to utilize the <b>Qingsong Health</b> AIcare technology stack as a foundation. This will support <b>Basel Medical</b> in upgrading its medical services with AI-native solutions across Southeast Asia and jointly expanding their regional market footprint, aiming to establish a durable and stable strategic partnership.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qingsong Health Shares Surge Over 20% in Afternoon Trading Following Strategic Partnership Announcement for Southeast Asia Expansion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQingsong Health Shares Surge Over 20% in Afternoon Trading Following Strategic Partnership Announcement for Southeast Asia Expansion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-22 14:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Qingsong Health</b> (<b>HKEX: 02661</b>) shares experienced a significant surge of over 20% in afternoon trading. At the time of writing, the stock was up 14.21% to HK$15.81, with a trading volume of HK$211 million.<br><br>\n<b>Catalyst for the Move</b><br><br>The recent price movement follows the company's announcement that it has entered into a three-year strategic cooperation memorandum with Basel Medical Group Limited (<b>Basel Medical</b>, <b>NASDAQ: BMGL</b>).<br><br>\nThe collaboration is centered around leveraging <b>Qingsong Health</b>'s proprietary MedClaw healthcare AI collaboration system and AIcare technology stack, along with its extensive experience in implementing AI within the health sector. The primary goal is to foster mutual development through both technology export and iterative technological advancements.<br><br>\nBoth parties believe that integrating the company's proven health AI infrastructure with <b>Basel Medical</b>'s established clinical presence and market access in Southeast Asia will accelerate the region's transition towards intelligent healthcare services. This partnership is expected to unlock new market opportunities for both entities.<br><br>\nFurthermore, the companies plan to utilize the <b>Qingsong Health</b> AIcare technology stack as a foundation. This will support <b>Basel Medical</b> in upgrading its medical services with AI-native solutions across Southeast Asia and jointly expanding their regional market footprint, aiming to establish a durable and stable strategic partnership.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02661","symbol_name":"轻松健康","start_time":0,"source_url":"","article_id":"1198594758","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198594758","pubTimestamp":1782108385,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Qingsong Health (HKEX: 02661) shares experienced a significant surge of over 20% in afternoon trading. At the time of writing, the stock was up 14.21% to HK$15.81, with a trading volume of HK$211...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159891":"医疗","02661":"轻松健康","BK1219":"保健护理服务","VXUS":"国际股票ETF-Vanguard","BK4588":"碎股","BK4585":"ETF&股票定投概念"},"translate_title":"宣布东南亚扩张战略合作伙伴关系后，青松健康股价午盘飙升逾20%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159891":1,"VXUS":1,"02661":1},"content_text":"Qingsong Health (HKEX: 02661) shares experienced a significant surge of over 20% in afternoon trading. At the time of writing, the stock was up 14.21% to HK$15.81, with a trading volume of HK$211 million.\nCatalyst for the MoveThe recent price movement follows the company's announcement that it has entered into a three-year strategic cooperation memorandum with Basel Medical Group Limited (Basel Medical, NASDAQ: BMGL).\nThe collaboration is centered around leveraging Qingsong Health's proprietary MedClaw healthcare AI collaboration system and AIcare technology stack, along with its extensive experience in implementing AI within the health sector. The primary goal is to foster mutual development through both technology export and iterative technological advancements.\nBoth parties believe that integrating the company's proven health AI infrastructure with Basel Medical's established clinical presence and market access in Southeast Asia will accelerate the region's transition towards intelligent healthcare services. This partnership is expected to unlock new market opportunities for both entities.\nFurthermore, the companies plan to utilize the Qingsong Health AIcare technology stack as a foundation. This will support Basel Medical in upgrading its medical services with AI-native solutions across Southeast Asia and jointly expanding their regional market footprint, aiming to establish a durable and stable strategic partnership.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1198594758","isCrawlerRequest":true}